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WE used the mouse air pouch model of in￿ amma-
tion to study the interaction between cytokines,
prostaglandin E2 (PGE2) and cell migration during
the various phases of acute local in￿ ammation
induced by carrageenan. In serum, the levels of
interleukin 1 (IL-1), interleukin 6 (IL-6), tumour
necrosis factor (TNF), serum amiloid-A (SAA) and
Fe were never different from controls, indi-
cating that no systemic in￿ ammatory changes
were induced. Locally the exudate volume and the
number of leukocytes recruited into the pouch
increased progressively until 7 days after carra-
geenan. The same was true for PGE2 production.
We could not measure IL-1 but the production of
IL-6 and TNF reached a maximum after 5± 24 h
then quickly decreased. Anti-TNF antibodies in-
hibited cell migration by 50% 24 h after treat-
ment. Pretreatment with interleukin 10 (IL-10)
inhibited TNF production almost completely and
cell migration by 60%. Carrageenan-induced in-
￿ ammation was modulated by anti-in￿ ammatory
drugs. Pretreatment with dexamethasone (DEX)
or indomethacin (INDO) inhibited cell migration
and reduced the concentration of TNF in the
exudate. Production of PGE2 or vascular per-
meability did not correlate with the number of
cells in the pouch. Local TNF seems to play an
important role in this model, particularly for
leukocyte migration in the ￿ rst phase of the
in￿ ammatory process. In conclusion, the air
pouch seems to be a good model for studying the
regulation of the early events of local in￿ amma-
tion, particularly the role of cytokines and cell
migration.
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Introduction
Many attempts have been made to correlate
serum tumour necrosis factor (TNF) levels with
the severity of different in￿ammatory diseases1
but clinical studies2 and experimental work3 in
various models of septic shock suggest that
systemic levels of TNF are not a good predictor
of the potential outcome of in￿ammation. How-
ever, in experiments of paw oedema induced by
carrageenan injection, the local amount of TNF
correlated with the swelling of the paw and it
was therefore considered a good indication of
the in￿ammatory status.3
On the other hand, TNF seems to be an
important mediator in the pathogenesis of
rheumatoid arthritis.4,5 Joint extracts from ar-
thritic rats had signi￿cantly higher TNF levels
(1054 147 pg g of tissue) than joint extracts
of normal rats (110 42 pg g of tissue).6 Anti-
TNF antibodies are protective in animal models
of arthritis7 and clinical studies have shown an
effect of anti-TNF antibodies in patients with
rheumatoid arthritis.8 We established an in vivo
model of acute local in￿ammation in the mouse.
This air pouch model of synovial in￿ammation,
described by Sedgwick and coworkers,9 consists
of a subcutaneous injection of air on the back
of rodents. This procedure induces the prolif-
eration of cells that stratify on the surface of the
cavity to form a structure similar to the synovia
after 6 days.10 Injection of carrageenan induces
in￿ammation and the pouch serves as a reser-
voir of cells and mediators that can be easily
measured in the ￿uid that accumulates locally.
We investigated the production of TNF in
relation to interleukin (IL)-1 and IL-6, which are
reported to be regulated by TNF in synovial
￿uid and in the serum of patients with rheuma-
toid arthritis,8 and in relation to leukocyte
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suppresses various leukocyte functions,11,12
dose-dependently regulating TNF production by
macrophages,13 we also studied PGE2 produc-
tion in the air pouch.
We characterized the experimental model
in terms of cytokine production as well as
PGE2 production, cell migration and vascular
permeability (measured as extravasation of
￿uorescently labelled bovine serum albumin).
The kinetics of all these parameters were
investigated during the in￿ammatory response.
We also investigated whether a systemic acute
phase response was induced. We measured
serum TNF , IL-6 and IL-1 as well as serum
amyloid A (SAA) and serum Fe as typical
markers of the acute phase response.14 We used
the cyclooxygenase inhibitor indomethacin
(INDO) to investigate the role of PGE2. We also
used dexamethasone (DEX) and IL-10 potent
inhibitors of the production of in￿ammatory
cytokines that are protective in animal models
of TNF-mediated endotoxic shock15,16 and an
anti-TNF antibody that neutralizes TNF in vivo
and protects against endotoxic shock.17 To
evaluate the role of the polymorphonuclear
leukocytes’ (PMN) recruitment in the produc-
tion of in￿ammatory mediators, we induced
neutropenia by pretreating mice with 5-￿uor-
ouracil (5-FU).
Materials and Methods
Animals
Male CD1 mice, 22± 25 g body weight (Charles
River Italy, Calco, CO) were used for all experi-
ments if not otherwise stated. The animals were
housed at constant temperature (20 18 C) and
relative humidity (60 10% ) and provided with
food and water ad libitum. All the procedures
involving animals and their care were con-
ducted in conformity with national and interna-
tional laws and policies (EEC Council Directive
86609, OJ L358, 1, 12 December 1987; Italian
Legislative Decree 116 92, Gazzetta Uf￿ciale
della Repubblica Italiana n. 40, 18 February
1992; NIH Guide for the Care and the Use of
Laboratory Animals, NIHpublication no. 85± 23,
1985).
Air pouch model
After a period of adaptation the animals were
anaesthetized with ether and 5 ml of air were
injected under the skin on their back. After 3
days the pouches were reinjected with 3 ml of
air. On day 6, 1 ml of 1%carrageenan (Sigma) in
saline was injected into the pouch. The controls
received 1 ml of saline. At different times after
carrageenan the animals were anaesthetized and
the pouches were washed with 1 ml of saline.
The lavage ￿uid was immediately cooled on ice
and the volume was recorded, then 50 ml were
used for cell count after staining with erythro-
sin. The remaining ￿uid was centrifuged at
5000 rpm for 10 min at 48 C and supernatants
were stored at 208 C until used for the
measure of PGE2, TNFor IL-6.
Materials
IL-10 was a kind gift from Schering Plough, Italy.
Dexamethasone phosphate was a kind gift from
Laboratorio Farmacologico Milanese S.R.L. (Car-
onno P . Varese, Italy); indomethacin, water-
soluble salt, was a commercial preparation from
Chiesi Farmaceeutici (Parma, Italy). All drugs
were given in saline. A rat anti-mouse TNF
monoclonal antibody (V1q) was prepared and
administered to mice as previously described.18
The speci￿city and activity of this antibody has
been described19 and it protects mice against
the lethality of LPS.18,19
Mediator assays
TNF was measured by a standard cytotoxicity
assay using L929 cells. IL-1 was measured using
a mouse ELISA kit purchased from Genzyme
(Cambridge, MA). IL-6 was measured as hybrido-
ma growth factor on 7TD1 cell line. PGE2 was
measured with a commercial ELISA kit (Amer-
sham, Little Chalfont, UK). Serum amyloid-A
was determined using an ELISA as previously
described.20
Measurement of plasma exudation
Plasma exudation in the pouch was measured
using ￿uorescein isothiocyanate-conjugated bo-
vine serum albumin (FITC-BSA) (Sigma Chemi-
cal Co., St Louis, MO). At different times after
carrageenan treatment, 0.6 mg mouse of ￿uor-
escein isothiocyanate-conjugated bovine serum
albumin dissolved in 0.2 ml of saline were
injected in the tail vein of the animals; 30 min
later the animals were anaesthetized with ether
and the blood was collected. Fluorescence of
the undiluted pouch ￿uid and of serum, diluted
1:10 in saline, were measured with the excita-
tion wavelength set at 490 nm and emission at
521 nm. Plasma exudation was calculated as the
￿uorescence in the pouch as a percentage of
that in serum.
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Data were analysed with one-way analysis of
variance coupled with Duncan’s test for multi-
ple comparisons or with Kruskal± Wallis non-
parametric test coupled with Sach’s test for
multiple comparisons.
Results
Characterization of the air pouch
carrageenan in¯ ammation model
Fig. 1 shows the kinetics of the volume of
exudate and leukocyte recruitment during carra-
geenan-induced in￿ammation in the air pouch.
The total number of leukocytes (Fig. 1A) was
very similar in control and treated groups until
5 h after treatment. From 24 h to 7 days there
was massive recruitment of cells into the
pouches of animals treated with carrageenan.
The cells were mostly PMN until 24 h after
treatment and changed to a prevalence of
macrophages from 48 hours on (data not
shown). After 24 h PMN amounted to 70± 80%
of the total. Fig. 1B shows the volume of
exudate recovered from the pouches after saline
(control) or 1 ml of 1%carrageenan. In saline-
treated animals the volume decreased due to
the absorption of the saline injected at time 0.
In carrageenan-treated animals the volume in-
creased from 24 h to 7 days.
TNF and IL-6 concentrations (Fig. 2A and B)
measured in the pouch, were undetectable in
control animals at all times. In carrageenan-
treated animals TNF and IL-6 both peaked 24 h
after treatment, then declined very rapidly.
Prostaglandin E2 in pouch exudates (Fig. 3A)
was never detectable in control animals but in
carrageenan-treated animals there was a contin-
uous increase from 5 h to 7 days. Plasma
exudation measured as the percentage of FITC-
BSA in the pouch compared with serum was
considered as an indicator of the changes of
vessel permeability induced by in￿ammation.
Injection of carrageenan into the pouch signi￿-
cantly increased plasma exudation after 30 min,
5 h and 24 h (Fig. 3B). IL-1b was never found in
pouch exudate (detection limit < 50 pg ml). T o
detect any systemic in￿ammatory effects after
carrageenan in the air pouch, we measured
circulating levels of IL-1b, IL-6, TNF and the
parameters associated with an acute phase
response: acute phase SAA and serum iron. We
did not ￿nd hypoferraemia and TNF , IL-1, IL-6
and SAA were all below the limit of detection
(data not shown), indicating that no systemic
in￿ammatory effects were induced. To investi-
gate whether the in￿ammation was con￿ned to
the periphery because of the structure of the
pouch or the type of stimulus, we injected
100 ng mouse of LPS into the pouch instead of
carrageenan. In this case TNF , measured 90 min
after treatment was increased both in pouch
exudate (21399 9389 pg ml) and in serum
(502 173 pg ml).
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FIG. 1. Time course of total leukocyte number (panel A) and volume of exudate (panel B) in carrageenan-induced
in¯ ammation. Animals were pretreated with 1 ml of sterile saline (± s ± ) or 1 ml of 1% carrageenan in sterile saline (± d ± ).
Data are the mean SD of at least eight animals. P < 0 05, P < 0 01 according to Duncan’s test for multiple
comparisons.
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the various parameters of
in¯ ammation
The effects of systemic treatment with the anti-
in￿ammatory drugs DEX or INDO are reported
in Table 1. Both inhibited cell migration, the
formation of exudate and the production of
TNF , IL-6 and PGE2. However DEX had much
more effect than INDO.
Effect of neutropenia
Neutropenia induced by pretreatment with 5-
FU (Table 2), as expected reduced the number
of leukocytes recruited into the pouch by
carrageenan and the amount of TNF measured
in the pouch. However the volume of exudate,
plasma exudation and the concentration of
PGE2 were not different from the group treated
with carrageenan alone.
FIG. 2. Time course of TNF (panel A) and IL-6 (panel B) in carrageenan-induced in¯ ammation. Animals were pretreated with
1 ml of sterile saline or 1 ml of 1% carrageenan in sterile saline (± d ± ). In saline-treated mice TNF and IL-6 were below the
detection limit which was 50 pg ml for TNF and 50 U ml for IL-6. Data are the mean SD of duplicate determinations on at
least eight animals.
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FIG. 3. Time course of PGE2 (panel A) and plasma exudation (panel B) in carrageenan-induced in¯ ammation. Animals were
pretreated with 1 ml of sterile saline or 1 ml of 1% carrageenan in sterile saline. In saline-treated animals PGE2 was below
the detection limit which was 20 pg ml. For the plasma exudation experiments FITC-BSA (0.6 mg mouse dissolved in
0.2 ml mouse of saline) was injected in the tail vein of animals 30 min before they were killed. Plasma exudation was
expressed as a percentage of ¯ uorescence in the pouch in relation to serum. Data are the mean SD of at least eight
animals. P < 0 05, P < 0 01 according to Duncan’s test for multiple comparisons.
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The protective effects of DEX and INDO,
associated with an inhibitory effect on TNF
production, suggest that TNF plays a role in this
model of in￿ammation. T o test this we used
anti-TNF antibodies and IL-10, which inhibits
TNF production. As shown in Table 3, anti-TNF
antibodies (injected with carrageenan) reduced
the induction of IL-6 in the exudate by 68%and
cell recruitment by 44% .
The dose of anti-TNF completely neutralized
the levels of endogenous TNF induced by
carrageenan (T able 3).
Reduction of in￿ammation associated with
a lowering of TNF levels was con￿rmed by
treating the animals with IL-10 (1 mg mouse)
administered into the pouch together with
carrageenan or i.p. immediately before carragee-
nan. After 24 h the volume of exudate was not
affected but TNF was inhibited by more than
90% in both experiments. Cell migration into
the pouch was reduced by 67% and 58%
respectively (data not shown).
Because mast cells were reported to be
present in the lining of the pouch, we induced
in￿ammation in a mast cell-de￿cient strain of
mice to investigate the role of TNF in their
granules. Table 4 reports a reduced in￿amma-
tory response 24 h after treatment. The inhibi-
tion of cell migration was particularly
signi￿cant.
Table 1. Effect of systemic treatment with dexamethasone or indomethacin on the in¯ ammation induced by carrageenan in
the mouse air pouch
Treatment Volume of exudate (ml) Total leukocytes
(3 106 ml)
TNF (pg ml) IL-6 (U ml) PGE2 (pg ml)
Saline 1 00 0 001 1 31 0 5 < 50 < 50 173 23
Carrageenan 1 42 0 08 28 95 8 4 1470 480 > 6250 > 3200
Carrageenan
Dexamethasone
1 02 0 06 0 62 0 19 < 50 < 50 983 659
Carrageenan
Indomethacin
1 17 0 08 13 8 1 35 110 40 3415 2061 1170 1523
One ml of sterile saline or 1 ml of 1% carrageenan in sterile saline were injected in 6 day-old pouches. 0.2% dexamethasone in drinking water
was administered from 12 h before carrageenan. Two doses of indomethacin (2 mg kg) were injected intraperitoneally 30 min before
carrageenan and 8 h later. Animals were killed 24 h after the irritant. Data are the mean SD of at least ® ve animals. P < 0 01, P < 0 05
according to Kruskal± Wallis and Sachs’s test for multiple comparisons.
Table 2. Effect of 5-¯ uorouracil on the in¯ ammation induced by carrageenan in the mouse air-pouch
Treatment Volume of exudate
(ml)
Leukocytes
(3 106 ml)
Plasma exudation
(% of ¯ uorescence)
TNF (pg ml) PGE2 (pg ml)
Saline 0 98 0 07 2 88 1 4 2 12 0 67 < 50 < 10
Carrageenan 1 52 0 08 16 4 1 7 3 56 1 27 487 249 1640 80
5-FU Saline 1 0 0 05 0 61 0 1 2 62 0 5 < 50 < 10
5-FU Carrageenan 1 40 0 17 2 1 1 9 3 67 0 89 101 29 1500 50
5-FU (150 mg kg) was injected subcutaneously in the hind leg in 0.2 ml of H2O together with the ® rst injection of air and a second dose was
given on Day 6 when 1% carrageenan (1 ml) was injected in the pouch. Animals were killed 24 h later. Each value is the mean SD of at least
eight different animals. P , 0 05, P , 0 01 according to Kruskal± Wallis and Sachs’s test for multiple comparisons.
Table 3. Effect of anti-TNF antibodies on the in¯ ammation induced by carrageenan in the mouse air pouch
Treatment Volume of exudate
(ml)
Total leukocytes
(3 106 ml)
TNF (pg ml) IL-6 (U ml) PGE2 (pg ml)
Saline 0 92 0 12 1 18 0 89 < 50 < 50 160 33
Carrageenan 1 57 0 17 15 47 7 19 949 542 3999 3035 1150 369
Carrageenan anti-TNF 1 38 0 18 8 72 3 75 < 50 1273 796 1233 251
Sterile saline (1 ml) or 1% carrageenan in sterile saline (1 ml) were injected in 6 day-old pouches. Anti-TNF antibodies (10 ml which diluted
1:12800 neutralizes 256 U of murine TNF) were injected into the pouches at time 0 together with carrageenan. The animals were killed 24 h
after treatment. Data are the mean SD of at least eight animals in two different experiments. P < 0 05, P < 0 01 compared with the
control group, P < 0 05, P < 0 01 compared with the carrageenan group according to Kruskal± Wallis and Sachs’s test for multiple
comparisons.
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The objective of this study was to investigate
the role of cytokines, particularly TNF , during
the ￿rst phase of acute in￿ammation and to
assess the relationship between these mediators
and the time course of the cell migration and
PGE2 production. Other commonly used models
of local in￿ammation, such as the subcutaneous
injection of turpentine21 or the carrageenan
paw oedema,22 give information on the oedema-
tous response, but do not allow easy measure-
ment of the cellular or humoral effects locally.
The advantage of the air pouch model lies in its
structural similarities with the synovial lining
tissue10 and the fact that the in￿ammatory
exudate can be easily sampled and quanti￿ed
for its cellular and biochemical composition. In
this experimental model only a local in￿amma-
tory response is induced, with none of the
systemic acute-phase changes usually observed
in other models of local in￿ammation, including
increases of IL-1, TNF , SAA, or hypoferraemia.23
The con￿nement of the in￿ammation to the site
of injection is not due to the particular struc-
ture of the pouch because TNF in serum was
measurable when LPS, even at a low dose, was
injected into the pouch. One possible explana-
tion for this effect is that carrageenan is a less
potent stimulus than LPS; it might also diffuse
less than LPS.
The amount of TNF measured in the pouch
seems to be related to the number of migrating
cells. After treatment with 5-FU, when no cells
are present in the pouch, TNF is below the
detection limit. In addition the peak of TNF , 24 h
after carrageenan, correlates with the increase of
cells in the pouch. However the kinetics of cell
in￿ltration is delayed compared with that of TNF
and, since TNF is not present in serum, a
possible source during the ￿rst phases might be
the tissue of the pouch. In fact the lining of the
pouch was reported to contain many mast
cells,24 the only cell type that stores TNF in the
granules.25 Therefore they might be the ￿rst
source of TNF after stimulation and the TNF
releasedfrommast cells was reported to account
for 40%of the PMNmigrationinto the peritoneal
cavity after immunocomplex-induced peritonitis
and Arthus reaction in rats.25 Using a mast cell-
de￿cientstrainof mice, carrageenan-induced cell
migration was reduced 40% , seemingly in agree-
ment with these data. However, the levels of
TNF induced by carrageenan were comparable
in normal and mast cell-de￿cient mice, indi-
cating that these cells do not contribute signi￿-
cantly to TNF production in this model
(evaluated 24 h after carrageenan). The protec-
tive effects of treatment with anti-TNFantibodies
or IL-10 on some parameters of carrageenan-
induced in￿ammation strengthen the suggestion
that TNFplays a role in the process.
The time course of the production of PGE2
parallels that obtained by Sin et al.26 although
the absolute amounts are completely different.
W e measured the PGE2 released spontaneously
in the exudate while Sin et al.26 measured it
both in cells and exudate. Since the increase of
PGE2 parallels the increase of cells in the pouch
PGE2 might be produced and released by
leukocytes recruited and activated by carragee-
nan. However, after treatment with 5-FU, which
induces neutropenia and prevents the accumu-
lation of cells, the amount of PGE2 was not
affected, so it might also be formed by the
pouch tissue and not by the migrating cells.
These data seem in agreement with the ones in
the rat reported by Sedgwick and Lees27 and by
Simmons et al.28
PGE2 has been shown to down-regulate TNF
production in vitro12 and INDO, by breaking
this negative feedback, potentiated LPS-induced
TNF synthesis both in vitro12,29 and in vivo. 30
W e obtained contrasting results. Pretreatment
with DEX or INDO reduced PGE2 synthesis but
also lowered TNF content. We measured TNF
and PGE2 after 24 h when the number of
leukocytes in the pouch without INDOpretreat-
ment was double that after INDO. Therefore if
TNF is produced by leukocytes these data are
not surprising.
Taken together the results indicate that TNF
is a mediator of in￿ammation in the carragee-
nan-induced mouse air pouch model.
Table 4. Effect of mast-cell de® ciency on carrageenan-induced in¯ ammation in the mouse air pouch
Volume of exudate
(ml)
Plasma exudation
(% of ¯ uorescence)
Total leukocytes
(3 106 ml)
TNF (pg ml) PGE2 (pg ml)
Controls 1 46 0 10 2 81 0 53 30 8 15 3 606 306 1066 472
WBC6F1 J-Sl Sl d 1 45 0 13 1 97 0 91 17 9 2 74 512 480 850 50
One ml mouse of 1% carrageenan in sterile saline was injected in 6 day-old pouches of both experimental groups. The animals were killed
24 h later. FITC-BSA (0.6 mg mouse) was injected i.v. 30 min before the death. Data are the mean SD of at least six animals. P < 0 05
according to Student’s t-test.
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